{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:48:35Z","timestamp":1792586915290,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.semnuclmed.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:15:38Z","timestamp":1779430538000},"page":"637-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["FDG PET for cardiac sarcoidosis: Protocol optimization, quantification, pitfalls, and multimodality imaging integration"],"prefix":"10.1053","volume":"56","author":[{"given":"Samuel B.","family":"Wopperer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9433-8568","authenticated-orcid":false,"given":"Ellen","family":"Kronzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Ivare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4615-9380","authenticated-orcid":false,"given":"Maryam","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panithaya","family":"Chareonthaitawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9923","key":"10.1053\/j.semnuclmed.2026.05.002_bib0001","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.002_bib0002","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/hrt.2005.080481","article-title":"Cardiac sarcoidosis","volume":"92","author":"Doughan","year":"2006","journal-title":"Heart"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.05.002_bib0003","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"37","key":"10.1053\/j.semnuclmed.2026.05.002_bib0004","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr\u00f6m","year":"2019","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1053\/j.semnuclmed.2026.05.002_bib0005","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1161\/CIR.0000000000001240","volume":"149","author":"Cheng","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2303\/jecho.5.1","article-title":"Cardiac sarcoidosis: what can we know from echocardiography?","volume":"5","author":"Yamano","year":"2007","journal-title":"J Echocardiogr"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.05.002_bib0007","article-title":"The role of echocardiography in the contemporary diagnosis and prognosis of cardiac sarcoidosis: a comprehensive review","volume":"13","author":"Okafor","year":"2023","journal-title":"Life (Basel)"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.05.002_bib0008","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jcmg.2024.07.011","article-title":"Myocardial strain imaging: theory, current practice, and the future","volume":"18","author":"Smiseth","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12872-019-01323-0","article-title":"Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis","volume":"20","author":"Di Stefano","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.05.002_bib0010","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/ehjci\/jez235","article-title":"Deterioration of biventricular strain is an early marker of cardiac involvement in confirmed sarcoidosis","volume":"21","author":"Kusunose","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.05.002_bib0012","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/echo.13281","article-title":"Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction","volume":"33","author":"Murtagh","year":"2016","journal-title":"Echocardiography"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.05.002_bib0013","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.echo.2015.02.018","article-title":"Myocardial damage detected by two-dimensional speckle-tracking echocardiography in patients with extracardiac sarcoidosis: comparison with Magnetic resonance imaging","volume":"28","author":"Orii","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0014","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1253\/circj.CJ-21-0265","article-title":"Deep learning algorithm to detect cardiac sarcoidosis from echocardiographic movies","volume":"86","author":"Katsushika","year":"2021","journal-title":"Circ J"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.05.002_bib0015","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/radiol.213170","article-title":"Diagnostic accuracy of cardiac MRI versus FDG PET for Cardiac sarcoidosis: a systematic review and meta-analysis","volume":"304","author":"Aitken","year":"2022","journal-title":"Radiology"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.05.002_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005022","article-title":"Comprehensive cardiovascular magnetic resonance assessment in patients with sarcoidosis and preserved left ventricular ejection fraction","volume":"9","author":"Greulich","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001728","article-title":"T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis","volume":"8","author":"Tonegawa-Kuji","year":"2021","journal-title":"Open Heart"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0018","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0019","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12968-023-00918-z","article-title":"Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study","volume":"25","author":"Treiber","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.05.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-098540","article-title":"Serial cardiac magnetic resonance imaging to assess myocardial inflammation in PET-positive cardiac sarcoidosis under immunomodulatory therapy: a retrospective observational study","volume":"15","author":"Treiber","year":"2025","journal-title":"BMJ Open"},{"issue":"15","key":"10.1053\/j.semnuclmed.2026.05.002_bib0021","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2009.04.094","article-title":"The role of cardiovascular magnetic resonance imaging in heart failure","volume":"54","author":"Karamitsos","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.05.002_bib0023","first-page":"901","article-title":"Magnetic resonance imaging of cardiac sarcoidosis: evaluation of the distribution of late gadolinium enhancement","volume":"32","author":"Komada","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.05.002_bib0024","first-page":"526","article-title":"Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy","volume":"68","author":"Sano","year":"2016","journal-title":"J Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.002_bib0025","article-title":"Cardiac sarcoidosis: the role of multimodality imaging in diagnosis and management","volume":"45","author":"Vereckei","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0026","first-page":"50","article-title":"Cardiac sarcoidosis\u2014state of the art review","volume":"6","author":"Hulten","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.05.002_bib0027","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"20","key":"10.1053\/j.semnuclmed.2026.05.002_bib0028","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"issue":"36","key":"10.1053\/j.semnuclmed.2026.05.002_bib0029","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1093\/eurheartj\/ehaf338","article-title":"Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement","volume":"46","author":"Mathijssen","year":"2025","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.05.002_bib0030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3348\/kjr.2025.0148","article-title":"Updates on cardiac MRI and PET imaging for the diagnosis and monitoring of cardiac sarcoidosis","volume":"26","author":"Oyama-Manabe","year":"2025","journal-title":"Korean J Radiol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.05.002_bib0031","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/a-0598-5099","article-title":"Diagnostic value of cardiac magnetic resonance strain analysis for detection of cardiac sarcoidosis","volume":"190","author":"Dabir","year":"2018","journal-title":"Rofo"},{"issue":"14","key":"10.1053\/j.semnuclmed.2026.05.002_bib0032","first-page":"2426","article-title":"Machine-learning-based diagnostics of cardiac sarcoidosis using multi-chamber wall motion analyses","volume":"13","author":"Eckstein","year":"2023","journal-title":"Diagn (Basel)"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.05.002_bib0033","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/j.semnuclmed.2024.02.004","article-title":"Imaging of cardiac sarcoidosis: an update and future aspects","volume":"54","author":"Saric","year":"2024","journal-title":"Semin Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.002_bib0034","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2967\/jnmt.124.268142","article-title":"Assessment of cardiac sarcoidosis with PET\/CT","volume":"53","author":"Liu","year":"2025","journal-title":"J Nucl Med Technol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.05.002_bib0035","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in Cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.05.002_bib0036","first-page":"930","article-title":"GLUT1 expression in tissue and (18)F-FDG uptake","volume":"45","author":"Avril","year":"2004","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.002_bib0037","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12350-019-01746-4","article-title":"Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: the effect of a structured patient preparation protocol","volume":"28","author":"Christopoulos","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.002_bib0038","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12350-009-9179-5","article-title":"Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: a randomized controlled trial","volume":"17","author":"Cheng","year":"2010","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.05.002_bib0039","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J Nucl Cardiol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.05.002_bib0040","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2967\/jnumed.121.261981","article-title":"Comparison of the effect of three different dietary modifications on myocardial suppression in 18F-FDG PET\/CT evaluation of patients for suspected cardiac sarcoidosis","volume":"62","author":"Ozutemiz","year":"2021","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.05.002_bib0041","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s12350-016-0477-4","article-title":"Continuing evolution in preparation protocols for 18FDG PET assessment of inflammatory or malignant myocardial disease","volume":"24","author":"Bois","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.05.002_bib0042","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s12350-023-03209-3","article-title":"Utility of serum ketone levels for assessment of myocardial glucose suppression for 18F-fluorodeoxyglucose PET in patients referred for evaluation of endocarditis","volume":"30","author":"Madamanchi","year":"2023","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.05.002_bib0043","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00259-022-06062-7","article-title":"The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies","volume":"50","author":"Alfawara","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.05.002_bib0044","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.002_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102088","article-title":"Quantification of metabolic activity in the evaluation of cardiac sarcoidosis","volume":"43","author":"Wiefels","year":"2025","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.05.002_bib0046","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jcmg.2019.12.013","article-title":"Effect of corticosteroid dose and duration on 18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"13","author":"Okada","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0047","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.05.002_bib0048","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ejhf.3057","article-title":"Predictors of outcome in a contemporary cardiac sarcoidosis population: role of brain natriuretic peptide, left ventricular function and myocardial inflammation","volume":"25","author":"Kouranos","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.05.002_bib0049","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jcmg.2024.05.013","article-title":"Risk stratification in cardiac sarcoidosis with cardiac positron emission tomography: a systematic review and meta-analysis","volume":"17","author":"Kafil","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.05.002_bib0050","first-page":"342","article-title":"Quantitative interpretation of FDG PET for cardiac sarcoidosis reclassifies visually interpreted exams and potentially impacts downstream interventions","volume":"35","author":"Varghese","year":"2018","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0051","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-020-02201-5","article-title":"Quantitative assessment of cardiac hypermetabolism and perfusion for diagnosis of cardiac sarcoidosis","volume":"29","author":"Miller","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"2 Pt 2","key":"10.1053\/j.semnuclmed.2026.05.002_bib0052","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.05.002_bib0053","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.002_bib0054","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s12350-021-02886-2","article-title":"18F-FDG\/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis","volume":"30","author":"Young","year":"2023","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12350-019-01659-2","article-title":"FDG-PET in possible cardiac sarcoidosis: right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events","volume":"28","author":"Tuominen","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.05.002_bib0056","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.05.002_bib0057","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-treatment myocardial 18FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.05.002_bib0058","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cardfail.2021.06.016","article-title":"Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review","volume":"28","author":"Gilotra","year":"2022","journal-title":"J Card Fail"},{"key":"10.1053\/j.semnuclmed.2026.05.002_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102195","article-title":"AI-enabled CT-guided end-to-end quantification of total cardiac activity in 18F-FDG PET\/CT for detection of cardiac sarcoidosis","volume":"48","author":"Miller","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102052","article-title":"Automated deep learning segmentation of cardiac inflammatory FDG PET","volume":"42","author":"Poitrasson-Rivi\u00e8re","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.05.002_bib0061","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.123.266905","article-title":"It's a trap! Aldolase-prescribed C4 deoxyradiofluorination affords intracellular trapping and the tracing of fructose metabolism by PET","volume":"65","author":"Kirby","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.05.002_bib0062","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s40001-026-04040-5","article-title":"Can FAPI-PET be used to evaluate cardiac fibroblast activation and predict left ventricular function in patients with cardiovascular diseases? A systematic review and meta-analysis","volume":"31","author":"Wang","year":"2026","journal-title":"Eur J Med Res"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.05.002_bib0063","first-page":"1286","article-title":"PET imaging in cardiac sarcoidosis: a narrative review with focus on novel PET tracers","volume":"14","author":"Saric","year":"2021","journal-title":"Pharm (Basel)"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:30:23Z","timestamp":1792585823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0001299826000930"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.05.002","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FDG PET for cardiac sarcoidosis: Protocol optimization, quantification, pitfalls, and multimodality imaging integration","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}